Form 8-K PharMerica CORP For: Aug 05
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
PharMerica (PMC) Tops Q2 EPS by 4c; Boosts FY14 Outlook
August 5, 2014 8:12 AM EDTPharMerica (NYSE: PMC) reported Q2 EPS of $0.40, $0.04 better than the analyst estimate of $0.36. Revenue for the quarter came in at $448.6 million versus the consensus estimate of $432.7 million.
PharMerica sees FY2014 EPS of $1.47-$1.52, versus prior guidance of $1.4-$1.5 and the consensus of $1.49. PharMerica... More
